[药物过量使用头痛患者的睡眠障碍]
I A Kniazeva1,2, D V Gilev3, E R Lebedeva1,2
1Ural State Medical University, Yekaterinburg, Russia.
Zhurnal nevrologii i psikhiatrii imeni S.S. Korsakova
|June 27, 2024
概括
药物过度使用头痛 (MOH) 的患者比没有MOH的患者更容易出现睡眠障碍,包括慢性失眠和不安腿综合征. 早期诊断和治疗这些睡眠问题对于管理MOH进展至关重要.
科学领域:
- 神经学 神经学
- 睡眠医学 睡眠医学
- 头痛 疾病 头痛 疾病
背景情况:
- 药物过度使用头痛 (MOH) 是频繁头痛治疗的常见并发症.
- 睡眠障碍在头痛患者中经常被报告,但它们与MOH的特定关联需要进一步调查.
研究的目的:
- 为了比较MOH患者的睡眠障碍投诉和诊断睡眠障碍的发生率,与没有MOH的初级头痛患者相比.
主要方法:
- 一项前性病例控制研究,涉及171名MOH患者和173名非MOH初级头痛患者.
- 神经学检查,专业面试和标准化尺度,包括国际睡眠障碍分类 (第三版). ),失眠严重程度指数,爱普沃思睡眠度量表和NoSAS.
- 基于国际睡眠障碍分类 (2014年第3版) 的睡眠障碍诊断.
主要成果:
- 患有MOH的患者报告睡眠丧失 (51.5%),经常醒来 (43.3%) 和不安腿综合征 (37.4%) 的比率显著更高.
- MOH患者的慢性失眠发生率较高 (60.2%对47.4%,p=0.02) 和不安腿综合征 (37.4%对22.0%,p=0.002).
- 困难入睡,白天嗜睡和打的发病率在各组之间是相似的;高睡眠症和阻塞性睡眠呼吸暂停综合征没有显著差异.
结论:
- 与非MOH头痛患者相比,MOH患者的睡眠障碍,特别是慢性失眠和不安腿综合征的患病率明显高.
- 这些发现强调了睡眠障碍在MOH病理生理学中的关键作用.
- 及时诊断和管理睡眠障碍对于预防MOH和睡眠障碍的恶化至关重要.
相关概念视频
Substance Use Disorders Affecting Sleep
164
Substance use disorders involve a pattern of using drugs more extensively than intended and continuing use despite harmful consequences. This includes legal substances like alcohol and nicotine, as well as illegal drugs. These disorders often involve both physical and psychological dependence, reflecting compulsive use of substances that significantly alter thoughts, feelings, and behaviors, contributing to a major public health issue.
Understanding the concepts of physical dependence,...
Understanding the concepts of physical dependence,...
164
Management of Insomnia
243
The sleep cycle, an integral part of human health, consists of several stages with distinct characteristics and functions. It begins with a transition from wakefulness to sleep, known as the light sleep phase, followed by the restorative deep sleep phase, essential for physical recovery and growth. The cycle concludes with the Rapid Eye Movement (REM) phase, characterized by high brain activity and vivid dreaming. Insomnia, a prevalent sleep disorder, involves difficulty falling asleep, staying...
243
Sedatives and Hypnotics Drugs: Miscellaneous Agents
167
Sedatives and hypnotics encompass a wide range of substances, each with its unique mechanism of action, uses, and potential adverse effects.
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
Melatonin congeners like ramelteon (Rozerem) and tasimelteon (Hetlioz) selectively bind to melatonin receptors (MT1 and MT2) and thus mimic the actions of melatonin, a hormone that regulates sleep-wake cycles. Tasimelteon is primarily used for non-24-hour sleep-wake disorder, common in blind patients. They are also used to treat conditions like insomnia...
167
Narcolepsy
101
Narcolepsy is a chronic sleep disorder characterized by pervasive, uncontrolled sleepiness and other sleep disturbances. One of its hallmark symptoms is an abrupt transition to REM sleep upon falling asleep, which causes symptoms typically associated with this phase to occur unexpectedly during wakefulness. These include the following symptoms, which typically last from a minute or two to half an hour.
101
Sedatives and Hypnotics: Overview
335
Sedatives are drugs that alleviate anxiety, while hypnotics induce sleep. Both classes of medication suppress neuronal activity, leading to a calming effect for sedatives and facilitating sleep for hypnotics.
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
Sedative-hypnotics are categorized into barbiturates, benzodiazepines (BZDs), and non-benzodiazepines or Z-drugs. These drugs work by suppressing central nervous system activity, and this suppression is dose-dependent. Older sedative medications, like barbiturates, follow a linear curve in...
335
CNS Depressants: Barbiturates and Benzodiazepines
243
CNS depressants include drugs from the category of barbiturates and benzodiazepines. They are valuable medications for managing anxiety disorders and insomnia. Barbiturates, once used to induce and maintain sleep, have been replaced mainly by benzodiazepines due to barbiturate's toxicity, tolerance, and overdose risks. They interact with GABAA receptors, leading to sedation at low doses and potentially coma and death at higher doses. Phenobarbital, a long-acting barbiturate, possesses...
243


